オリゴヌクレオチド合成の世界市場予測2021：プライマー、プローブ、カスタム、デザイン済み、試薬、装置...市場調査レポートについてご紹介

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 25)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 33)

4 Premium Insights (Page No. – 38)
4.1 Oligonucleotide Synthesis Market Overview
4.2 Synthesized Oligonucleotides Market, By Product
4.3 Market, By Service
4.4 Market, By Research Application
4.5 Market, By Therapeutic Application
4.6 Market, By End User
4.7 Geographic Snapshot: Oligonucleotide Synthesis Market

5 Market Overview (Page No. – 42)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Technological Advancements and R&D Investments in Synthetic Biology
5.2.1.2 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
5.2.1.3 Increasing R&D Expenditure in Pharmaceutical & Biotechnology Companies
5.2.1.4 Rise in Venture Capital Investments
5.2.1.5 Growing Focus on Conferences to Increase Awareness Among Researchers
5.2.2 Market Restraints
5.2.2.1 Price Erosion of Synthesized Oligos
5.2.2.2 Lack of Regulations for Therapeutic Oligos
5.2.3 Market Opportunities
5.2.3.1 Emerging Asian Markets
5.2.3.2 Developing Fields of Personalized Medicine and Next-Generation Sequencing
5.2.4 Market Challenges
5.2.4.1 Localization of Business
5.2.4.2 Large-Scale Synthesis of Oligonucleotides
5.2.4.3 Delivery of Oligonucleotide Drug to Specific Target
5.3 Industry Trends
5.4 Porter’s Five Forces Analysis
5.4.1 Threat of New Entrants
5.4.2 Threat of Substitutes
5.4.3 Bargaining Power of Suppliers
5.4.4 Bargaining Power of Buyers
5.4.5 Intensity of Competitive Rivalry
5.5 Supply Chain Analysis
5.5.1 Key Influencers

6 Oligonucleotide Synthesis Market, By Product & Service (Page No. – 56)
6.1 Introduction
6.2 Synthesized Oligonucleotides
6.2.1 Synthesized Oligonucleotides Market, By Product
6.2.1.1 Primers
6.2.1.2 Probes
6.2.1.3 Large-Scale Synthesis Oligos
6.2.1.4 Intermediate-Scale Synthesis Oligonucleotides
6.2.1.5 Linkers and Adaptors
6.2.2 Synthesized Oligonucleotides Market, By Service
6.2.2.1 Custom Oligonucleotides
6.2.2.2 Pre-Designed Oligonucleotides
6.2.3 Reagents
6.2.4 Equipment

7 Oligonucleotide Synthesis Market, By Application (Page No. – 83)
7.1 Introduction
7.2 Research
7.2.1 PCR
7.2.2 QPCR
7.2.3 Sequencing
7.2.4 Gene Synthesis
7.2.5 Other Research Applications
7.3 Diagnostics
7.4 Therapeutics
7.4.1 Rnai
7.4.2 Nucleic Acid Aptamers
7.4.3 DNA/Antisense Oligos
7.4.4 Immunotherapy Applications

8 Oligonucleotide Synthesis Market, By End User (Page No. – 113)
8.1 Introduction
8.2 Academic Research Institutes
8.3 Pharmaceutical and Biotechnology Companies
8.4 Diagnostic Laboratories
8.5 Other End Users

9 Oligonucleotide Synthesis Market, By Region (Page No. – 126)
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Rest of Europe (RoE)
9.4 Asia-Pacific (APAC)
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia-Pacific (RoAPAC)
9.5 Latin America (Latam)
9.6 Middle East and Africa (MEA)

10 Competitive Landscape (Page No. – 182)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Situation and Trends
10.3.1 Partnerships, Agreements, Contracts, and Collaborations
10.3.2 Product Launches, Upgrades, and Licenses
10.3.3 Expansions
10.3.4 Acquisitions
10.3.5 Others

11 Company Profiles (Page No. – 192)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Introduction
11.2 Integrated DNA Technologies, Inc.
11.3 Merck KGaA
11.4 Eurofins Genomics
11.5 Thermo Fisher Scientific Inc.
11.6 Bioautomation Corporation
11.7 Agilent Technologies, Inc.
11.8 Eurogentec S.A.
11.9 General Electric (GE) Company
11.10 LGC Biosearch Technologies, Inc.
11.11 Nitto Denko Avecia Inc.

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 235)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Other Developments, By Company, 2013–2016
12.3.1 Product Launches, Upgrades, and Licenses
12.3.2 Expansions
12.3.3 Acquisitions.
12.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.5 Introducing RT: Real-Time Market Intelligence
12.6 Available Customizations
12.7 Related Reports
12.8 Author Details